Amino.Desk

GLP-3, GLP1-R, reta: what seller code names mean

Updated Nov 17, 2026 · Clinical review: pending

Online sellers of unapproved peptides often list weight-loss drugs under short codes instead of their real names. "GLP-3" is the best known. None of these codes is an official drug name, and none tells you what is in a vial.

There is no GLP-3 hormone and no GLP-3 drug class. The term is slang for retatrutide, Eli Lilly's experimental drug, which is not approved and cannot legally be sold for human use.

What the codes usually mean

Name on a listing or in a postUsually refers toWhere it is documented
GLP-3, "reta", "r3ta", "ratatouille"RetatrutidePublic Citizen report, June 2026
GLP1-R, GLP-1-RRetatrutideFDA warning letters, March 31, 2026
Triple GRetatrutideEli Lilly lawsuit, August 2026
GLP1-TTirzepatideFDA warning letter, March 31, 2026
GLP-2TirzepatideFDA warning letter, March 31, 2026
GLP1-SSemaglutideFDA warning letter, March 31, 2026

The codes are not standardized. The two FDA letters above show two sellers using different codes for the same drug in the same month, and sellers change them when a name gets blocked. Treat the table as a guide to what people mean, not as proof of what a product contains.

Where the numbers come from

The numbering counts hormone receptors. Semaglutide acts on one (GLP-1). Tirzepatide acts on two (GLP-1 and GIP). Retatrutide acts on three (GLP-1, GIP and glucagon). Sellers turned that into "GLP-1", "GLP-2" and "GLP-3".

It is misleading. GLP-2 is a real and entirely different gut hormone that tirzepatide does not act on. And there is no hormone called GLP-3.

Why sellers and influencers use codes

"Research use only" does not make it legal

Listings that use these codes usually carry a line such as "for laboratory research only, not for human consumption". The FDA has rejected that defense in writing. In a March 2026 warning letter, it said the disclaimer was contradicted by the seller's own website, which described weight loss, blood sugar and appetite effects in people. It also treated the bacteriostatic water the seller offered in a kit with a syringe as an unapproved drug.

Enforcement has not cleared the market. Public Citizen counted 14 FDA warning letters to retatrutide sellers since December 2024 and found that, as of May 2026, 11 of those sellers were still advertising retatrutide or other unapproved peptides.

What is known about the products

In Lilly's words, what is sold on the black market "is not a medicine".

If you see one of these codes

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy